Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02415166 · ClinicalTrials.gov registry record · NA
Influenza Challenge in Mood Disorders
A NA study, sponsored by Laureate Institute for Brain Research.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02415166 is a NA study that was terminated before completion, run by Laureate Institute for Brain Research. The registered enrollment target is 6 participants.
The verdict
NCT02415166, a NA study, was terminated before completion, sponsored by Laureate Institute for Brain Research.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The aim of this project is to evaluate the efficacy of the influenza vaccine in individuals with major depressive disorder (MDD) as well as to elucidate the nature of the immunological abnormalities in MDD using a quasi-experimental design. Specifically, the investigators plan to induce transient, mild inflammation in medically-healthy study participants using the influenza vaccine. Initially the investigators will conduct a pilot project with up to 20 individuals in order to evaluate the time-point at which the peak inflammatory response to the vaccine occurs. Subjects will receive the seasonal influenza vaccine and provide blood samples 4 hours, 2 days, and 30 days post vaccination. Subsequent to the pilot study, both depressed and psychiatrically-healthy participants will be randomized in a parallel group, double-blind design so that they receive either influenza vaccine (seasonal vaccine) or saline (i.m). At baseline, subjects will provide a blood sample, complete a number of rating scales to measure mood and fatigue, and may complete approximately one hour of MRI scanning with or without simultaneous EEG recording. Two-days post vaccination, they will provide a second blood sample, complete more clinical ratings and may complete another identical MRI session with or without simultaneous EEG. Four weeks later, participants will be asked to return to provide a third blood sample and complete additional clinical ratings. The blood samples will be used to measure both innate and adaptive immune function and may be used to correlate the vaccine-induced immunological changes to neurophysiological changes in the brain measured by MRI and/or EEG.
Interventions
- BIOLOGICAL INFLUENZA VACCINE
- OTHER NaCl-saline placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02415166
The ClinicalTrials.gov registry entry for NCT02415166 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Laureate Institute for Brain Research, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which INFLUENZA VACCINE is the first listed.
NCT02415166 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02415166 about?
NCT02415166 is a clinical study titled "Influenza Challenge in Mood Disorders". The aim of this project is to evaluate the efficacy of the influenza vaccine in individuals with major depressive disorder (MDD) as well as to elucidate the nature of the immunological abnormalities in MDD using a quasi-experimental design. Specifically, the investigators plan to induce transient, m...
What is the current status of trial NCT02415166?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2015-07. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02415166?
The interventions under investigation include: INFLUENZA VACCINE (BIOLOGICAL), NaCl-saline placebo (OTHER).
Who is sponsoring clinical trial NCT02415166?
This trial is sponsored by Laureate Institute for Brain Research, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.